99mTc-DARPinG3

DRUG2 trials

Sponsors

Tomsk National Research Medical Center of the Russian Academy of Sciences

Conditions

Breast Cancer FemaleFemaleHER2-positive Breast Cancer

Unknown Phase

Molecular Imaging of HER2 Expression in HER2-positive Breast Cancer Using 99mTc-ADAPT6 vs 99mTc-DARPinG3

CompletedNCT05376644

Tomsk National Research Medical Center of the Russian Academy of SciencesBreast Cancer Female

Start: 2022-05-01End: 2023-01-21Updated: 2026-06-29

99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy

CompletedNCT05412459

Tomsk National Research Medical Center of the Russian Academy of SciencesFemale, HER2-positive Breast Cancer

Start: 2022-05-01End: 2023-01-31Updated: 2026-06-24